Vaccines against Coccidioides

被引:6
作者
Yoon, Hee Jung
Clemons, Karl V.
机构
[1] Division of Infectious Diseases, Department of Internal Medicine, Eulji University Hospital, Daejeon
[2] California Institute for Medical Research, Stanford University School of Medicine, Stanford, CA
关键词
ANTIIDIOTYPIC ANTIBODIES;
D O I
10.3904/kjim.2013.28.4.403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vaccines against fungal diseases are gaining attention because of their growing impact on modern medicine. Development of these vaccines should incorporate immunological tools that integrate with or replace chemotherapy to minimize antibiotic use and consequent resistance. In this review, we evaluate the current developmental status of fungal vaccines against coccidioidomycosis. There is a need for a vaccine that sufficiently prevents disease, without eradicating the fungus, by neutralizing adhesions and enzymes or other low penetrance virulence traits.
引用
收藏
页码:403 / 407
页数:5
相关论文
共 10 条
  • [1] Immunological Reactivity of Blood from Healthy Humans to the rAls3p-N Vaccine Protein
    Baquir, Beverlie
    Lin, Lin
    Ibrahim, Ashraf S.
    Fu, Yue
    Avanesian, Valentina
    Tu, Ang
    Edwards, John, Jr.
    Spellberg, Brad
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (03) : 473 - 477
  • [2] Fungal vaccines: real progress from real challenges
    Cassone, Antonio
    [J]. LANCET INFECTIOUS DISEASES, 2008, 8 (02) : 114 - 124
  • [3] Universal Vaccines: Shifting to One for Many
    Cassone, Antonio
    Rappuoli, Rino
    [J]. MBIO, 2010, 1 (01):
  • [4] Clemons K.V., 2011, The Journal of Invasive Fungal Infections, V5, P99
  • [5] A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
    Pachl, J
    Svoboda, P
    Jacobs, F
    Vandewoude, K
    van der Hoven, B
    Spronk, P
    Masterson, G
    Malbrain, M
    Aoun, M
    Garbino, J
    Takala, J
    Drgona, L
    Burnie, J
    Matthews, R
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (10) : 1404 - 1413
  • [6] POLONELLI L, 1991, J MED VET MYCOL, V29, P235
  • [7] POLONELLI L, 1994, J IMMUNOL, V152, P3175
  • [8] An anti-β-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo
    Rachini, Anna
    Pietrella, Donatella
    Lupo, Patrizia
    Torosantucci, Antonella
    Chiani, Paola
    Bromuro, Carla
    Proietti, Carla
    Bistoni, Francesco
    Cassone, Antonio
    Vecchiarelli, Anna
    [J]. INFECTION AND IMMUNITY, 2007, 75 (11) : 5085 - 5094
  • [9] Developing a vaccine against aspergillosis
    Stevens, David A.
    Clemons, Karl V.
    Liu, Min
    [J]. MEDICAL MYCOLOGY, 2011, 49 : S170 - S176
  • [10] A novel glyco-conjugate vaccine against fungal pathogens
    Torosantucci, A
    Bromuro, C
    Chiani, P
    De Bernardis, F
    Berti, F
    Galli, C
    Norelli, F
    Bellucci, C
    Polonelli, L
    Costantino, P
    Rappuoli, R
    Cassone, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) : 597 - 606